User:Mr. Ibrahem/Brodalumab

Brodalumab, sold under the brand name Siliq and Kyntheum, is a medication used to treat plaque psoriasis. Specifically it is used for moderate to severe disease in people who have not improved with other treatments. It is given by injection under the skin.

Common side effects include joint pain, headache, tiredness, diarrhea, throat pain, nausea, low white blood cells, and tinea infections. Other side effects may include infection and Crohn's disease. Safety in pregnancy is unclear. It is a monoclonal antibody which blocks interleukin 17.

Brodalumab was approved for medical use in the United States and Europe in 2017. In the United Kingdom 4 weeks of medication costs the NHS about £1,300 as of 2021. In the United States this amount costs about 2,800 USD.